BBR Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History

BBR Partners’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100,000	Closed	-$4.57M	–	106
2017 Q4	$4.57M	Buy	+100,000	New	+$4.99M	0.86%	10
2016 Q1	–	Sell	-35,000	Closed	-$1.54M	–	86
2015 Q4	$1.54M	Buy	+35,000	New	+$1.74M	0.24%	15

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

BBR Partners's JUNO Position: Q1 2018 in Review

BBR Partners sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 100,000 shares — an estimated $4.57M sold.

BBR Partners first reported a position in JUNO in Q4 2015 and held it in 2 quarters. The position peaked at $4.57M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

BBR Partners reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
BBR Partners sold 100,000 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $4.57M.
BBR Partners first reported a position in Juno Therapeutics, Inc. in Q4 2015 and held it in 2 quarters.
BBR Partners's Juno Therapeutics, Inc. position peaked at $4.57M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on BBR Partners's 13F filing for Q1 2018, filed 10 May 2018.